Detection of highly ionized O and Ne absorption lines in the X-ray spectrum of 4U1820-303 in the globular cluster, NGC 6624

We searched for absorption lines of highly ionized O and Ne in the energy spectra of two Low-mass X-ray binaries, 4U1820-303 in the globular cluster NGC6624 and Cyg X-2, observed with the Chandra LETG, and detected O VII, O VIII and Ne IX absorption lines for 4U1820-303. The equivalent width of the O VII K alpha line was 1.19 +0.47/-0.30 eV (90 % errors) and the significance was 6.5 sigma. Absorption lines were not detected for Cyg X-2 with a 90 % upper limit on the equivalent width of 1.06 eV for O VII K alpha. The absorption lines observed in 4U1820-303 are likely due to hot interstellar medium, because O will be fully photo-ionized if the absorbing column is located close to the binary system. The velocity dispersion is restricted to b = 200 - 420 km/s from consistency between O VII K alpha and K beta lines, Ne/O abundance ratio, and H column density. The average temperature and the O VII density are respectively estimated to be log(T[K]) = 6.2 - 6.3 and n(OVII) = (0.7 - 2.3) x 10^{-6} cm^{-3}. The difference of O VII column densities for the two sources may be connected to the enhancement of the soft X-ray background (SXB) towards the Galactic bulge region. Using the polytrope model of hot gas to account for the SXB we corrected for the density gradient and estimated the midplane O VII density at the solar neighborhood. The scale height of hot gas is then estimated using the AGN absorption lines. It is suggested that a significant portion of both the AGN absorption lines and the high-latitude SXB emission lines can be explained by the hot gas in our Galaxy.Comment: Accepted for publication in ApJ. 7 pages, 9 eps figure

Impaired secretion of growth hormone-releasing hormone, growth hormone and IGF-I in elderly men

The GHRH test and L-dopa test were performed in 12 normal young men (24.1 ± 1.1 years) and 12 normal elderly men (77.8±1.4 years) to investigate age-related changes in secretion of GHRH, GH and IGF-I. The basal plasma levels of GHRH and GH were not significantly different in young and elderly men, but the basal plasma level of IGF-I was higher in the young men (159.0± 11.7 vs 86.7± 11.6 μg/l). The area under the curve for plasma GH in the GHRH test was less in the elderly group (35.1 ±5.9 vs 11.2 ± 2.1 μg · h−1 · 1−1, p<0.001). The AUCs for the plasma GHRH and GH responses in the L-dopa test in young and elderly men were 32.0±2.7 vs 20.3±1.8 ng · h−1 · 1−1 (p<0.001), and 21.8±4.6 vs 5.4±1.1 μg · h−1 · 1−1 (p<0.01), respectively, indicating decreased releases of GHRH and GH in the elderly. Correlations between the AUCs for plasma GHRH and GH responses in L-dopa were found in both groups, but the ratio of the AUCs for GH/GHRH was lower in the elderly group. The elderly group showed a significant correlation between the basal plasma IGF-I level and the AUCs for plasma GH in the GHRH and L-dopa tests. These results suggest that elderly men have a decreased reserve of hypothalamic GHRH, resulting in secondarily impaired GH release, which may lead to a lower level of IGF-I than in young men

GH and GHRH responses to L-dopa in Cushing's disease

The function of the growth hormone-releasing hormone (GHRH)-growth hormone (GH) axis in Cushing's disease was studied by monitoring (a) the GH responses to GHRH loading and L-dopa loading, (b) the GHRH response to L-dopa loading, and (c) the daytime profiles of plasma GH concentration. GH release following GHRH and L-dopa was blunted in patients as compared to that in age-matched control subjects. However, GHRH release following L-dopa was similar in patients and controls. The plasma GH levels in four patients measured every 20 min by a highly sensitive immunoradiometric assay for GH showed pulsatile GH secretion at low levels during the observation period. These results indicate that GHRH release from the hypothalamus is preserved in patients with Cushing's disease, and support the hypothesis that glucocorticoid inhibits GH secretion by altering the hypothalamic somatostatin tone

FOUR RELEASING HORMONE TEST AND L-DOPA TEST

Hypothalamic-pituitary function was evaluated in a combination of tests with four hypothalamic releasing hormones (4RHs) and L-dopa in normal subjects and in patients with hypothalamic and/or pituitary disorders. Plasma concentrations of anterior pituitary hormones (GH, ACTH, TSH, PRL, LH and FSH) were measured before and after simultaneous iv administration of GHRH, CRH, TRH and LHRH. In addition, changes in the plasma levels of GHRH and GH were investigated before and after oral administration of L-dopa. Normal subjects showed appreciable responses to both tests. In five patients with hypothalamic disorders, the response of plasma anterior pituitary hormones varied, but plasma GHRH and GH did not respond to L-dopa. Patients with idiopathic and postpartum hypopituitarism showed low response to 4RHs or none at all, but L-dopa evoked a normal GHRH response in 2 of the 4 cases having no GH response. In the patients with hypopituitarism due to resection of a pituitary tumor, the response of anterior pituitary hormones to 4RHs was low, and L-dopa administration induced a normal GHRH and low GH response in 5 out of the 7 cases. After 4RHs administration, the patients with ACTH deficiency syndrome showed different patterns of impaired ACTH secretion, and isolated, combined or limited ACTH reserve. Seven patients with anorexia nervosa showed exaggerated GH, delayed TSH and FSH, low ACTH and LH, that is, normal PRL response to 4RHs, but no response of plasma GHRH or GH to L-dopa, suggesting the presence of hypothalamic dysfunction. These results indicate that the combination of the 4RHs test and L-dopa test is a simple and useful means for evaluating hypothalamic-pituitary function by measuring the response of plasma GHRH and six anterior pituitary hormones in the patients with endocrine disorders

CORRELATION OF ACTH AND CORTISOL LEVELS BY IRMA

Using a new ACTH-immunoradiometric assay (IRMA), we measured plasma ACTH levels in the basal states and during CRH test in normal subjects and the patients with hypothalamo-pituitary disorders. The basal levels of plasma ACTH in 76 normal young (25-45 yr) and 140 elderly (60-85 yr) subjects were 23.1 +/- 13.6, and 17.5 +/- 11.2 pg/ml, respectively. The plasma ACTH levels were less than detection limit (5 pg/ml) in 3 patients with isolated ACTH deficiency, and less than 10 pg/ml in 6 of 7 patients with hypopituitarism. A significant correlation was observed between the basal levels of plasma ACTH and of cortisol in two age groups, with almost the same regression line, showing no age-related decline in the plasma levels of ACTH and cortisol. In 2 normal subjects and 2 patients with Cushing's disease, synchronized secretions of ACTH and cortisol were observed between 0800h and 1800h. In normal subjects and the patients with pituitary disorders, a significant correlation was observed between the Area Under the Curve's for plasma ACTH and cortisol during the CRH test. The correlation constant was higher in normal subjects, but lower in the patients with acromegaly, non-functioning pituitary tumor, and Cushing's disease in this order, suggesting low sensitivity of the pituitary-adrenal axis in these patients. These results suggest that the ACTH-IRMA kit provide reliable data for clinical investigation, and that the secretions of ACTH and cortisol correlate each other in basal states and during the CRH test in the patients with pituitary disorders as well as in normal subjects

GH RESPONSES AND PATHOLOGY IN ACROMEGALY

Plasma growth hormone (GH) responses to various stimuli were examined in 21 patients with GH-producing pituitary adenomas, classified into three types by the immunohistochemistry of cytokeratin and the glycoprotein hormone α-subunit distribution. Seven type 1 adenomas were exclusively composed of cells in which the cytokeratin formed a dot-like pattern; they were chromophobic to hematoxylin and eosin (H & E), occasionally positive for GH, and almost completely negative for the α-subunit. Thirteen type 2 adenomas were composed of cells with cytokeratin that had a perinuclear distribution; they were eosinophilic to H & E, and diffusely positive for both GH and the α-subunit. One patient had a type 3 adenoma which had a mixed pattern of intracellular cytokeratin distribution and was chromophobic and eosinophilic to H & E. Clinically, type 1 is characterized by earlier onset, larger tumor size, and more frequent aggressive extension. Paradoxical GH responses to TRH and OGTT were seen in 1 of 6 patients (16.7%) of type 1 and 8 of 9 patients (88.9%) of type 2, and 0% of type 1 and 62.5% of type 2, respectively. Type 2 cases showed higher plasma GH response to GH-releasing hormone, and a tendency to greater suppression of plasma GH by bromocriptine compared with type 1. Octreotide acetate administration revealed that the nadir/basal ratio of plasma GH levels was 42.9±6.6% in type 1 and 13.5±5.8% in type 2. These results suggest that there is a pathophysiological difference between these two distinct types of GH-producing pituitary adenomas

Performance measurement of the 8-input SQUIDs for TES frequency domain multiplexing

金沢大学大学院理工研究域数物科学系We report on performance of 8-input superconducting quantum interference devices (SQUIDs) for multiplexing transition-edge sensor signals by using frequency-domain multiplexing. We found the typical critical current and the flux noise to be 17-19 μA and 0.7-1.1 μΦ0/Hz, respectively. We also measured the crosstalk current between the input coils of the SQUIDs, and found that the mutual inductance was consistent with the design value, 800 pH. We confirmed that the cross talk current due to the mutual inductance was reduced by the flux-locked-loop (FLL) feedback, and its reduction rate was consistent with 1/(1+L), where L is the FLL feedback gain. We also show the result of 2-channel DC-driven TES signals readout using the 8-input SQUIDs. © Springer Science+Business Media, LLC 2008

X-ray Spectral Study of the extended emission,'the Cap', located 11.6 kpc above the disk of M82

The extended X-ray emission from 'the Cap' region located 11' (11.6 kpc) above the disk of the starburst galaxy M82 has been observed with Suzaku and XMM-Newton. Owing to the good energy resolution and the large collecting area of the XIS on Suzaku, combined with similar properties of the EPIC instrument on XMM-Newton, we have clearly detected K-shell emission lines from O VII, O VIII, Ne X, Mg XI, Mg XII and the Fe-L complex. Two optically-thin thermal plasma components are required to fit the observed X-ray spectra. We have determined the metal abundances of O, Ne, Mg, Si and Fe in this region for the first time. Their metal abundance ratios agree well with those of metal-poor stars and the model prediction of metals synthesized by type-II supernovae, but they are not consistent with the metallicities of type-Ia supernovae. This result is support for the idea that the origin of the metals in the Cap is type-II supernovae explosions occurring in the starburst regions in the M82 galaxy. We discuss the possible contribution from sputtered dust grains to the metals in the Cap. An emission line consistent with the C VI transition of n=4 to 1 at 0.459 keV is marginally detected, although it is not statistically significant at the 99% confidence level; the presence of this line would suggest charge-exchange processes in the Cap.Comment: 16 pages, 10 figuer

On the lack of strong O-line excess in the Coma cluster outskirts from Suzaku

About half of the baryons in the local Universe are thought to reside in the so-called warm-hot intergalactic medium (WHIM) at temperatures of 0.1-10 million K. Thermal soft excess emission in the spectrum of some cluster outskirts that contains OVII and/or OVIII emission lines is regarded as evidence of the WHIM, although the origin of the lines is controversial due to strong Galactic and solar system foreground emission. We observed the Coma-11 field, where the most prominent thermal soft excess has ever been reported, with Suzaku XIS in order to make clear the origin of the excess. We did not confirm OVII or OVIII excess emission. The OVII and OVIII intensity in Coma-11 is more than 5 sigma below that reported before and we obtained 2 sigma upper limits of 2.8 and 2.9 photons cm^-2 s^-1 sr^-1 for OVII and OVIII, respectively. The intensities are consistent with those in another field (Coma-7) that we measured, and with other measurements in the Coma outskirts (Coma-7 and X Com fields with XMM-Newton). We did not confirm the spatial variation within Coma outskirts. The strong oxygen emission lines previously reported are likely due to solar wind charge exchange.Comment: 5 pages, 3 figures. Accepted for publication in Ap